{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:49:16Z","timestamp":1792324156782,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["1403\\u20132\\u2013104-64,951"],"award-info":[{"award-number":["1403\\u20132\\u2013104-64,951"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["1404\\u20136\\u2013104-92,269"],"award-info":[{"award-number":["1404\\u20136\\u2013104-92,269"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioorg.2026.109482","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:09:11Z","timestamp":1767802151000},"page":"109482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design, synthesis, and antidiabetic evaluation of triazolopyrimidine thioacetamides as potent and selective \u03b1-glucosidase inhibitors"],"prefix":"10.1016","volume":"170","author":[{"given":"Fariba","family":"Peytam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Norouzbahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Bayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin Ozan","family":"G\u00fclcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Sheibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Barazandeh Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Mojtabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Faramarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Torabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghdad","family":"Payab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loghman","family":"Firoozpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Foroumadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109482_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115734","article-title":"Diabetes mellitus: classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments","volume":"168","author":"Antar","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109482_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70412","article-title":"New Quinazolin-4 (3H)-one\u2013Thiazolidine-2, 4-Dione hybrids as dual inhibitors of \u03b1-glycosidase and aldose reductase: the synthetic, in vitro, and in silico approaches","volume":"39","author":"Tokal\u0131","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2026.109482_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108614","article-title":"Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4 (3H)-one derivatives with 4-Bromo-2-Fluorobenzene functionality","author":"Tokal\u0131","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.127487","article-title":"Aldose reductase inhibition properties of novel thiazolidin-2, 4-diones: in vitro and in silico approach for the treatment of diabetes-related complications","volume":"426","author":"Tokal\u0131","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.109482_bb0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-8587(23)00223-1","article-title":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","volume":"11","author":"Kaptoge","year":"2023","journal-title":"The Lancet Diabetes & Endocrinol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109482_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7705","article-title":"Potential gains in life expectancy associated with achieving treatment goals in US adults with type 2 diabetes","volume":"5","author":"Kianmehr","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bioorg.2026.109482_bb0035","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.3390\/molecules26154566","article-title":"Inhibitory activity and mechanism investigation of hypericin as a novel \u03b1-glucosidase inhibitor","volume":"26","author":"Dong","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109482_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70033","article-title":"Quinazolin-4 (3H)-one-based new Glitazones as dual inhibitors of \u03b1-glucosidase and aldose reductase: comprehensive approaches for managing diabetes mellitus and its complications","volume":"358","author":"Tokal\u0131","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.109482_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1345\/aph.1G336","article-title":"Hepatotoxicity associated with acarbose therapy","volume":"40","author":"Hsiao","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109482_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106276","article-title":"Chromone-based benzohydrazide derivatives as potential \u03b1-glucosidase inhibitor: synthesis, biological evaluation and molecular docking study","volume":"131","author":"Fan","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bmcl.2019.01.012","article-title":"Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: in vitro \u03b1-glucosidase inhibition, kinetic, and in silico studies","volume":"29","author":"Adib","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109482_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11030-019-09925-8","article-title":"Design and synthesis of new imidazo [1, 2-b] pyrazole derivatives, in vitro \u03b1-glucosidase inhibition, kinetic and docking studies","volume":"24","author":"Peytam","year":"2020","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.109482_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105423","article-title":"Discovery of new 2-phenyl-1H-benzo [d] imidazole core-based potent \u03b1-glucosidase inhibitors: synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation","volume":"117","author":"Li","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129290","article-title":"Synthesis and biological evaluation of new dihydroindolizino [8, 7-b] indole derivatives as novel \u03b1-glucosidase inhibitors","volume":"1224","author":"Peytam","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109482_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106028","article-title":"Flavone-1, 2, 3-triazole derivatives as potential \u03b1-glucosidase inhibitors: synthesis, enzyme inhibition, kinetic analysis and molecular docking study","volume":"127","author":"Dhameja","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106384","article-title":"Design, synthesis, biological evaluation, and docking study of chromone-based phenylhydrazone and benzoylhydrazone derivatives as antidiabetic agents targeting \u03b1-glucosidase","volume":"132","author":"Fan","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107177","article-title":"Thiazolidine-2, 4-dione derivatives as potential \u03b1-glucosidase inhibitors: synthesis, inhibitory activity, binding interaction and hypoglycemic activity","volume":"144","author":"Li","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107783","article-title":"Molecular hybridization, synthesis, in vitro \u03b1-glucosidase inhibition, in vivo antidiabetic activity and computational studies of isatin based compounds","volume":"153","author":"Patil","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107956","article-title":"Apigenin analogs as \u03b1-glucosidase inhibitors: molecular docking, biochemical, enzyme kinetic, and an in vivo mouse model study","volume":"153","author":"Liu","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108027","article-title":"Design, synthesis, biological evaluations and in silico studies of (Z)-2-(2, 4-dioxothiazolidin-5-ylidene) methyl-2-ethoxyphenyl-alkyl\/arylsulfonates as potential \u03b1-glucosidase inhibitors","volume":"154","author":"Dahiya","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108155","article-title":"Design, synthesis, in-vitro and in-silico studies of novel N-heterocycle based hydrazones as \u03b1-glucosidase inhibitors","volume":"156","author":"Farooqi","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0110","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/acsmedchemlett.2c00405","article-title":"Fragment-based dynamic combinatorial chemistry for identification of selective \u03b1-glucosidase inhibitors","volume":"13","author":"Wu","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109482_bb0115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2019.01.027","article-title":"1, 2, 4-Triazolo [1, 5-a] pyrimidines in drug design","volume":"165","author":"Oukoloff","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0120","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3390\/pharmaceutics14061191","article-title":"Synthesis and biological evaluation of highly active 7-anilino triazolopyrimidines as potent antimicrotubule agents","volume":"14","author":"Oliva","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.109482_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103260","article-title":"Novel [1, 2, 4] triazolo [1, 5-a] pyrimidine derivatives as potent antitubulin agents: design, multicomponent synthesis and antiproliferative activities","volume":"92","author":"Yang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0130","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/jm801343r","article-title":"Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice","volume":"52","author":"Gujjar","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103411","article-title":"Synthesis of 1, 2, 4-triazolo [1, 5-a] pyrimidine derivatives: antimicrobial activity, DNA gyrase inhibition and molecular docking","volume":"94","author":"Abd El-Aleam","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104841","article-title":"Design, synthesis and mechanistic study of new 1, 2, 4-triazole derivatives as antimicrobial agents","volume":"111","author":"Amin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ejmech.2007.04.021","article-title":"Synthesis, antifungal activity and CoMFA analysis of novel 1, 2, 4-triazolo [1, 5-a] pyrimidine derivatives","volume":"43","author":"Chen","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0150","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/S0960-894X(02)00525-5","article-title":"Synthesis and initial SAR studies of 3, 6-disubstituted pyrazolo [1, 5-a] pyrimidines: a new class of KDR kinase inhibitors","volume":"12","author":"Fraley","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109482_bb0155","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1038\/s41598-020-59079-z","article-title":"An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo [1, 5-a] pyrimidines with \u03b1-glucosidase inhibitory activity","volume":"10","author":"Peytam","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109482_bb0160","doi-asserted-by":"crossref","first-page":"11911","DOI":"10.1038\/s41598-021-91473-z","article-title":"Design, synthesis, molecular docking, and in vitro \u03b1-glucosidase inhibitory activities of novel 3-amino-2, 4-diarylbenzo [4, 5] imidazo [1, 2-a] pyrimidines against yeast and rat \u03b1-glucosidase","volume":"11","author":"Peytam","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109482_bb0165","doi-asserted-by":"crossref","first-page":"15672","DOI":"10.1038\/s41598-023-42549-5","article-title":"Imidazo [1, 2-c] quinazolines as a novel and potent scaffold of \u03b1-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies","volume":"13","author":"Peytam","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109482_bb0170","doi-asserted-by":"crossref","first-page":"27507","DOI":"10.1038\/s41598-024-78878-2","article-title":"Design, synthesis, and evaluation of novel substituted imidazo [1, 2-c] quinazoline derivatives as potential \u03b1-glucosidase inhibitors with bioactivity and molecular docking insights","volume":"14","author":"Peytam","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109482_bb0175","first-page":"1","article-title":"Design, synthesis, and evaluation of triazolo [1, 5-a] pyridines as novel and potent \u03b1-glucosidase inhibitors","volume":"15","author":"Peytam","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109482_bb0180","doi-asserted-by":"crossref","first-page":"39667","DOI":"10.1038\/s41598-025-23387-z","article-title":"Identification of novel triazolopyrimidines as potent \u03b1-glucosidase inhibitor through design, synthesis, biological evaluations, and computational analysis","volume":"15","author":"Peytam","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109482_bb0185","doi-asserted-by":"crossref","first-page":"32360","DOI":"10.1021\/acsomega.2c03779","article-title":"Synthesis, characterization, and enzyme inhibition properties of 1, 2, 4-triazole bearing azinane analogues","volume":"7","author":"Abdullah Asif","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.109482_bb0190","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/13880209.2019.1642363","article-title":"Alpha-glucosidase and amylase inhibitory effects of Eruca vesicaria subsp. longirostris essential oils: synthesis of new 1, 2, 4-triazole-thiol derivatives and 1, 3, 4-thiadiazole with potential inhibitory activity","volume":"57","author":"Hichri","year":"2019","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bioorg.2026.109482_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106844","article-title":"Design, synthesis, biological evaluation, and docking study of new triazole-phenylacetamide derivatives as \u03b1-glucosidase inhibitors","volume":"141","author":"Luo","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135321","article-title":"Synthesis, structure and \u03b1-glucosidase inhibitor activity evaluation of some acetamide derivatives starting from 2-(naphthalen-1-yl) acetic acid, containing a 1, 2, 4-triazole","volume":"1284","author":"Le","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109482_bb0205","article-title":"New 4-(arylidene) amino-1, 2, 4-traizole-5-thiol derivatives and their acyclo thioglycosides as \u03b1-glucosidase and \u03b1-amylase inhibitors: design, synthesis, and molecular modelling studies","volume":"1259","author":"El Sayed","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109482_bb0210","doi-asserted-by":"crossref","first-page":"22508","DOI":"10.1021\/acsomega.3c00702","article-title":"Synthesis and in vitro \u03b1-amylase and \u03b1-glucosidase dual inhibitory activities of 1, 2, 4-triazole-bearing bis-hydrazone derivatives and their molecular docking study","volume":"8","author":"Khan","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.109482_bb0215","first-page":"652","article-title":"$ S $-substituted derivatives of 1, 2, 4-triazol-3-thiol as new drug candidates for type II diabetes","volume":"42","author":"Rehman","year":"2018","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0220","article-title":"Exploring the antidiabetic efficacy of 3-mercapto-1, 2, 4-triazoles as potential inhibitors of \u03b1-amylase and \u03b1-glucosidase: A comprehensive review","volume":"147418","author":"Panhotra","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.109482_bb0225","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.tet.2011.01.062","article-title":"Synthesis of polysubstituted 5-aminopyrimidines from \u03b1-azidovinyl ketones and amidines","volume":"67","author":"Hu","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.109482_bb0230","doi-asserted-by":"crossref","first-page":"13563","DOI":"10.1074\/jbc.M113.460436","article-title":"Specificity of processing \u03b1-glucosidase I is guided by the substrate conformation: crystallographic and in silico studies","volume":"288","author":"Barker","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0235","first-page":"24240","article-title":"Torsional diffusion for molecular conformer generation","volume":"35","author":"Jing","year":"2022","journal-title":"Adv. Neural Inf. Proces. Syst."},{"key":"10.1016\/j.bioorg.2026.109482_bb0240","doi-asserted-by":"crossref","first-page":"31536","DOI":"10.1038\/s41598-025-14699-1","article-title":"Integrating data augmentation and BERT-based deep learning for predicting alpha-glucosidase inhibitors derived from black cohosh","volume":"15","author":"Torabi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109482_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0308308","article-title":"Exploration of alpha-glucosidase inhibitors: A comprehensive in silico approach targeting a large set of triazole derivatives","volume":"19","author":"Abchir","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.109482_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116832","article-title":"Insights into the molecular-level details of betaine interactions with laccase under various thermal conditions","volume":"339","author":"Mojtabavi","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.109482_bb0255","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1080\/00958972.2015.1042375","article-title":"Synthesis, structures, catalytic, and anticancer activities of some coordination compounds involving two new triazole derivatives","volume":"68","author":"Xiao","year":"2015","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.bioorg.2026.109482_bb0260","first-page":"1","article-title":"Benzalacetophenone: chalcone","volume":"2","author":"Kohler","year":"1992","journal-title":"Org. Synth."},{"key":"10.1016\/j.bioorg.2026.109482_bb0265","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1016\/j.tet.2017.09.042","article-title":"A new synthetic strategy towards 2, 4, 5-trisubstituted 1H-imidazoles and highly substituted pyrrolo [1, 2-c] imidazoles by use of \u03b1-azidochalcones via Michael addition-cyclization followed by Wittig reaction","volume":"73","author":"Adib","year":"2017","journal-title":"Tetrahedron"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:17:39Z","timestamp":1770067059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":53,"alternative-id":["S0045206826000180"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109482","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and antidiabetic evaluation of triazolopyrimidine thioacetamides as potent and selective \u03b1-glucosidase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109482"}}